INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.42 Cr | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr | ₹0.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.42 Cr |
| Mar2024 | ₹-4.58 Cr |
| Mar2023 | ₹0.53 Cr |
| Mar2022 | ₹2.91 Cr |
| Mar2021 | ₹0.22 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.42 Cr | Positive | |
| Mar2024 | ₹-4.58 Cr | Negative | |
| Mar2023 | ₹0.53 Cr | -81.91 | |
| Mar2022 | ₹2.91 Cr | 1,192.44 | |
| Mar2021 | ₹0.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹203.9 Cr | 5.2% | -30% | -38.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,734.2 Cr | 0.4% | -17.4% | -7.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,037.7 Cr | 0.2% | -3.8% | -31.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,720.2 Cr | 7% | -8.4% | -19.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹802.7 Cr | -3.9% | -15.5% | -36.1% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹388.6 Cr | 4.9% | -13.1% | -29.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 5.2% |
-30% |
-38.5% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses